Technical Analysis for CSBR - Champions Oncology, Inc.

Grade Last Price % Change Price Change
D 4.32 -5.05% -0.23
CSBR closed down 5.05 percent on Wednesday, November 20, 2024, on 35 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Dec 10
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Gapped Down Weakness 0.00%
NR7 Range Contraction -5.05%
Stochastic Reached Overbought Strength -5.05%
Gapped Up Strength -5.05%
Overbought Stochastic Strength -5.05%
Up 3 Days in a Row Strength -5.05%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Champions Oncology, Inc. Description

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Bank Biotechnology Cancer Technology Solutions Tumor Drug Development Cancer Care Molecular Partners Patient's Tumor

Is CSBR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.1303
52 Week Low 3.6001
Average Volume 64,347
200-Day Moving Average 4.85
50-Day Moving Average 4.48
20-Day Moving Average 4.27
10-Day Moving Average 4.49
Average True Range 0.27
RSI (14) 47.64
ADX 17.26
+DI 18.76
-DI 20.41
Chandelier Exit (Long, 3 ATRs) 3.89
Chandelier Exit (Short, 3 ATRs) 4.56
Upper Bollinger Bands 4.78
Lower Bollinger Band 3.77
Percent B (%b) 0.55
BandWidth 23.48
MACD Line 0.03
MACD Signal Line 0.00
MACD Histogram 0.0297
Fundamentals Value
Market Cap 58.73 Million
Num Shares 13.6 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -6.08
Price-to-Sales 1.67
Price-to-Book 876.29
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.89
Resistance 3 (R3) 4.93 4.79 4.80
Resistance 2 (R2) 4.79 4.64 4.77 4.76
Resistance 1 (R1) 4.55 4.55 4.48 4.51 4.73
Pivot Point 4.41 4.41 4.37 4.39 4.41
Support 1 (S1) 4.17 4.26 4.10 4.13 3.91
Support 2 (S2) 4.03 4.17 4.00 3.88
Support 3 (S3) 3.79 4.03 3.84
Support 4 (S4) 3.75